Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival
Publication date
2019-04
Authors
Kroeze, S G C
Fritz, C
Kaul, D
Blanck, O
Kahl, K
Roeder, F
Siva, S
Verhoeff, Joost
Grosu, A L
Schymalla, M M
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Hematology, Oncology
Citation
Kroeze, S G C, Fritz, C, Kaul, D, Blanck, O, Kahl, K, Roeder, F, Siva, S, Verhoeff, J J C, Grosu, A L, Schymalla, M M, Glatzer, M, Szuecs, M, Geier, M, Skazikis, G, Sackerer, I, Lohaus, F, Eckert, F & Guckenberger, M 2019, 'Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC : Clinical scenarios affecting survival', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 30 , no. Supplement 2, pp. ii63. https://doi.org/10.1093/annonc/mdz063.071